| Pharmaceutical Information |
| Drug Name |
Fibrinogen |
| Drug ID |
BADD_D00895 |
| Description |
Fibrinogen concentrate (human) is a hematological agent. It works by replacing a certain protein in the blood that helps with blood clotting. Fibrinogen (factor I) is a soluble plasma glycoprotein with a molecular weight of about 340 kDa. It is a physiological substrate for three enzymes: plasmin, factor XIIIa and thrombin. It is indicated for the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia. |
| Indications and Usage |
For the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia. |
| Marketing Status |
approved |
| ATC Code |
Not Available |
| DrugBank ID |
DB09222
|
| KEGG ID |
D04182
|
| MeSH ID |
D005340
|
| PubChem ID |
90540
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
63833-891 |
| UNII |
BP8KW73WMG
|
| Synonyms |
Fibrinogen | Blood Coagulation Factor I | Coagulation Factor I | Factor I, Coagulation | Factor I | gamma-Fibrinogen | gamma Fibrinogen |
|
| Chemical Information |
| Molecular Formula |
C6H14O6 |
| CAS Registry Number |
25878-23-3 |
| SMILES |
C(C(C(C(C(CO)O)O)O)O)O |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
